JP/ZH: Currently, only the Luminex LTG section and the Service & Support pages regarding Luminex LTG are available in Japanese/Chinese.
31/07/26 - 12:50
Revenue and EBITDA Supported by Strong Q2 Growth in the First Half of the Year. 2026 Guidance Confirmed. (277.39 KB)
20/05/26 - 11:16
Diasorin Board of Directors approves the 2026-2030 Business Plan (246.32 KB)
08/05/26 - 17:54
Revenues and EBITDA in line with the expected quarterly revenue trend and impacted by a weak flu season. 2026 Guidance confirmed (256.38 KB)
20/03/26 - 17:44
Revenues and EBITDA growth in line with FY 2025 Guidance. Proposed ordinary dividend per share of €1.30, +8.3% vs 2024 (349.08 KB)
08/11/13 - 1:00
The Board of Directors approves the Q3'13 Results (766.57 KB)
01/08/13 - 2:00
The Board of Directors approves the results for the H1 '13 (386.67 KB)
10/05/13 - 2:00
The Board of Directors approves the results for Q1'13 (763.61 KB)
02/05/13 - 2:00
Compensation Commitee-Errata corrige (179.38 KB)
22/04/13 - 2:00
Shareholders' meeting approves FY Results 2012 (57.22 KB)
08/03/13 - 1:00
The BoD approves FY 2012 results (477.24 KB)
07/03/13 - 1:00
Notification of changes in share capital (46.86 KB)
07/03/13 - 1:00
Notice availability By-Laws (36.87 KB)
07/02/13 - 1:00
Notification of changes in share capital (46.89 KB)
07/02/13 - 1:00
Notice availability By-Laws (139.13 KB)
30/01/13 - 1:00